Full Text View
Tabular View
No Study Results Posted
Related Studies
Bone Remodeling Around HA-Coated Acetabular Cups.
This study is ongoing, but not recruiting participants.
First Received: September 9, 2005   Last Updated: October 26, 2007   History of Changes
Sponsored by: Northern Orthopaedic Division, Denmark
Information provided by: Northern Orthopaedic Division, Denmark
ClinicalTrials.gov Identifier: NCT00159497
  Purpose

This study was designed to investigate the influence of HA-coating on bone remodeling around the cup in cementless THA.

100 patients gave informed consent to participate in a controlled randomized study between porous coated Trilogy® versus Trilogy Calcicoat®. The cup was inserted in press-fit fixation. The femoral component was a cementless porous coated titanium alloy stem (Bi-Metric®), with a modular 28 mm CrCo head.

Effect parameters were Harris Hip Score (HHS) and Bone Mineral Density (BMD) determined by DEXA scanning.

Measurements revealed no difference between the two groups after 3 years, neither in clinical outcome nor in terms of periprosthetic bone density.

Patients with Body Mass Index above normal regained more bone mineral than patients with normal weight. This finding supports the assumption that load is beneficial to bone remodeling. Advantages of better sealing of the bone-prosthesis interface, preventing polyethylene induced osteolysis, may still be anticipated for the 7 or 12 year follow-up examinations


Condition Intervention Phase
Coxarthrosis
Device: porous coated Trilogy®
Device: Trilogy Calcicoat®
Phase IV

MedlinePlus related topics: Minerals
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Subject), Active Control, Parallel Assignment, Efficacy Study
Official Title: Bone Remodeling Around HA-Coated Acetabular Cups.

Further study details as provided by Northern Orthopaedic Division, Denmark:

Primary Outcome Measures:
  • Changes in bone mineral density around the hip prosthesis, measured by DEXA scanning [ Time Frame: 8-12 years ]

Secondary Outcome Measures:
  • Changes in hip performance, measured by Harris Hip Score [ Time Frame: 8-12 years ]

Enrollment: 100
Study Start Date: October 1998
Estimated Study Completion Date: July 2012
Arms Assigned Interventions
1: Active Comparator
Standard porouscoated Trilogy Cup
Device: porous coated Trilogy®
THA
2: Experimental
HA coated Trilogy cup
Device: Trilogy Calcicoat®
THA

Detailed Description:

This study was designed to investigate the influence of HA-coating on bone remodeling around the cup in cementless THA.

100 patients gave informed consent to participate in a controlled randomized study between porous coated Trilogy® versus Trilogy Calcicoat®. The cup was inserted in press-fit fixation. The femoral component was a cementless porous coated titanium alloy stem (Bi-Metric®), with a modular 28 mm CrCo head.

Effect parameters were Harris Hip Score (HHS) and Bone Mineral Density (BMD) determined by DEXA scanning.

Measurements revealed no difference between the two groups after 3 years, neither in clinical outcome nor in terms of periprosthetic bone density.

Patients with Body Mass Index above normal regained more bone mineral than patients with normal weight. This finding supports the assumption that load is beneficial to bone remodeling. Advantages of better sealing of the bone-prosthesis interface, preventing polyethylene induced osteolysis, may still be anticipated for the 7 or 12 year follow-up examinations

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients eligible for cementless THA

Exclusion Criteria:

  • Medical conditions interfering with bone metabolism
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00159497

Locations
Denmark, Northern Jutland
Northern Orthopaedic Division, Klinik Farsoe
Farsoe, Northern Jutland, Denmark
Sponsors and Collaborators
Northern Orthopaedic Division, Denmark
Investigators
Principal Investigator: Mogens B Laursen, MD Northern Orthopaedic Division
  More Information

Additional Information:
No publications provided

Study ID Numbers: ON-04-001-MBL
Study First Received: September 9, 2005
Last Updated: October 26, 2007
ClinicalTrials.gov Identifier: NCT00159497     History of Changes
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics

Keywords provided by Northern Orthopaedic Division, Denmark:
THA

Study placed in the following topic categories:
Musculoskeletal Diseases
Osteoarthritis
Joint Diseases
Arthritis
Rheumatic Diseases
Osteoarthritis, Hip

Additional relevant MeSH terms:
Musculoskeletal Diseases
Osteoarthritis
Joint Diseases
Arthritis
Rheumatic Diseases
Osteoarthritis, Hip

ClinicalTrials.gov processed this record on May 06, 2009